Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$413K Buy
1,173
+59
+5% +$21K 0.36% 66
2025
Q4
$365K Buy
1,114
+42
+4% +$13.3K 0.27% 71
2025
Q3
$303K Sell
1,072
-148
-12% -$42.9K 0.24% 76
2025
Q2
$341K Buy
1,220
+5
+0.4% +$1.42K 0.28% 69
2025
Q1
$379K Buy
1,215
+204
+20% +$60.2K 0.32% 61
2024
Q4
$264K Sell
1,011
-213
-17% -$63.2K 0.17% 92
2024
Q3
$394K Sell
1,224
-19
-2% -$6.21K 0.15% 105
2024
Q2
$388K Buy
1,243
+276
+29% +$81.1K 0.24% 69
2024
Q1
$275K Sell
967
-203
-17% -$59.4K 0.17% 100
2023
Q4
$337K Sell
1,170
-580
-33% -$158K 0.21% 83
2023
Q3
$470K Buy
1,750
+276
+19% +$68.9K 0.22% 66
2023
Q2
$327K Sell
1,474
-239
-14% -$55.5K 0.19% 79
2023
Q1
$414K Sell
1,713
-202
-11% -$49.6K 0.23% 69
2022
Q4
$503K Sell
1,915
-512
-21% -$137K 0.28% 64
2022
Q3
$547K Buy
2,427
+1
+0% +$242 0.34% 51
2022
Q2
$590K Buy
2,426
+683
+39% +$167K 0.36% 50
2022
Q1
$422K Sell
1,743
-67
-4% -$15.4K 0.34% 52
2021
Q4
$397K Sell
1,810
-664
-27% -$140K 0.25% 64
2021
Q3
$528K Buy
2,474
+1,310
+113% +$302K 0.3% 51
2021
Q2
$288K Buy
+1,164
New +$286K 0.23% 58

Other funds holding AMGN

Eagle Bay Advisors's AMGN Position: Q1 2026 in Review

Eagle Bay Advisors increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $21K and bringing the position to 1,173 shares worth $413K. The position accounts for 0.36% of the portfolio, ranked #66.

Eagle Bay Advisors first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $590K in Q2 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Eagle Bay Advisors held 1,173 shares of Amgen worth $413K as of Q1 2026.
  • Eagle Bay Advisors bought 59 Amgen shares in Q1 2026, an estimated $21K.
  • Amgen made up 0.36% of Eagle Bay Advisors's portfolio in Q1 2026, its #66 holding.
  • Eagle Bay Advisors first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
  • Eagle Bay Advisors's Amgen position peaked at $590K in Q2 2022.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.